首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1373381

全球听力学设备市场 - 2023-2030

Global Audiology Devices Market - 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

由于从大脑到耳朵的神经通路的改变，老年人更容易出现听力损失。听力学设备用于检测和治疗听力损失或异常。听力学设备通常称为助听器，用于监测和研究人们的听力问题。

助听器、人工耳蜗和骨锚式听觉植入物都可以帮助听力损失患者。助听器使用内建麦克风、扩大机和扬声器来放大声音。这些是声音放大设备，旨在帮助有听力障碍的人。

市场动态：驱动因素与限制因素

设备启动数量增加

由于先进设备能够提供高效的听力解决方案，预计其数量的增加将推动市场成长。

例如，2023 年 9 月 25 日，人工智慧助听器和音讯解决方案供应商 ELEHEAR 推出了首款 OTC 助听设备，包括 ELEHEAR Alpha 和 ELEHEAR Alpha Pro。

2023 年 8 月 7 日，Unitron 推出了 Moxi V-RS，这是一款新型可充电听力设备，该设备在该公司最近推出的 Vivante 平台上运行。

此外，2022 年 10 月 17 日，Lexie Hearing 推出了由 Bose 支援的 Lexie B2 助听器，为其听力学家品质的助听器产品套件添加了第三种助听器型号。此外，听力损失患者数量的增加以及产品技术的进步也推动了市场的成长。

克制

与设备相关的高成本

在没有保险的情况下，人工耳蜗的平均费用为 30,000 美元至 50,000 美元。因此，由于成本高昂，大多数人买不起这些设备，这可能会阻碍市场成长。

Hearing loss is more likely in elderly people due to alterations in the neurological route from the brain to the ear. Audiology devices are used to detect and treat hearing loss or abnormalities. Audiology devices are commonly known as hearing aids and are used to monitor and study hearing issues in people.

Hearing aids, cochlear implants, and bone-anchored auditory implants all help people with hearing loss. A hearing aid amplifies sound using a built-in microphone, amplifier, and speaker. These are sound-amplifying devices designed to aid people who have a hearing impairment.

Market Dynamics: Drivers & Restraints

Increase in the number of device launches

The increase in the number of highly advanced device launches is expected to drive market growth due to their ability to provide hearing solutions with high efficiency.

For instance, on September 25, 2023, ELEHEAR, a provider of AI-powered hearing aids and audio solutions, introduced its first OTC hearing aid devices, these include the ELEHEAR Alpha and ELEHEAR Alpha Pro.

On August 7, 2023, Unitron launched Moxi V-RS, a new rechargeable hearing device, that operates on the company's recently launched Vivante platform.

Additionally, on October 17, 2022, Lexie Hearing launched the Lexie B2 Hearing Aids, Powered by Bose, adding a third hearing aid model to its suite of audiologist-quality hearing aid products. Furthermore, the increase in the number of patients with hearing loss, and technological advancements of the products also drive the market growth.

Restraint

High costs associated with the devices

The average cost of cochlear implants can range from $30,000 to $50,000 without insurance. Thus, most people cannot afford the devices due to their high cost, which can hamper the market growth.

Segment Analysis

The global audiology devices market is segmented based on technology, product type, indication, distribution channel and region.

Cochlear implants segment accounted for 56.3% of the market share

Cochlear implants segment has been holding a significant position in the market share. Cochlear implants are electronic devices that improve hearing in people who have severe hearing loss due to damage to the inner ear. The increase in the launches of advanced cochlear devices is expected to drive the growth of the segment.

For instance on August 18, 2023, Cochlear Limited, introduced its next-generation Cochlear Osia System with the ability to have an MRI at 3.0 T, designed to improve hearing outcomes for people with conductive hearing loss.

For instance, in August 2021, Cochlear Limited launched the Nucleus Kanso 2 Sound Processor in Singapore. The new launch reflects Cochlear's ongoing commitment to innovation in hearing technology to provide amplified access to smartphone connectivity and help to improve hearing performance in people with hearing loss. Thus, the increased launches of advanced products that help with hearing are expected to drive the segment growth.

Geographical Analysis

North America is expected to hold a significant position in the global audiology devices market share

North America has been a dominant force in the audiology devices market owing to the increase in the number of hearing issues. The increase in the aged population and the presence of a number of medical device manufacturers in the region also act as the driving factors of the market growth in the region. It is expected to continue throughout the forecast period.

For instance, according to the report published by the National Council on Aging, Inc. in 2023, it is estimated that 48 million Americans currently experience hearing loss to some degree. The number of Americans with hearing loss is expected to increase by 30 million in the next four decades.

Additionally, according to the article published by the National Institute of Health in March 2022, Otosclerosis affects more than three million Americans. Many cases of otosclerosis are thought to be inherited. Otosclerosis is a condition in which the bones inside the ear cause gradual hearing loss. Thus, increase in the number of cases with hearing loss increases the demand for the audiology devices, which is expected to drive the market growth.

COVID-19 Impact Analysis:

The pandemic has significantly impacted the global audiology device market. Patients with routine consultation and follow-up care were interrupted due to hospitals delivering only emergency services. Therefore, many patients were neglected from hearing disorder treatment as it is considered as a non-emergency treatment. Thus, COVID-19 has impacted negatively on the market growth.

Competitive Landscape

The leading companies with a significant market share include: Oticon Medical, Med-EL, Starkey Hearing Technologies, Phonak, Advanced Bionics, Audina Hearing Instruments, Inc., Coselgi, Sonova AG, WS Audiology A/S, and BHM-Tech Produktionsgesellschaft mbH among others.

Key Developments

On August 29, 2023, Lucid Hearing launched its Tala over-the-counter (OTC) hearing aid product line. Texas-based Lucid Hearing designed Tala with Bluetooth-compatible wireless streaming.
On June 21, 2023, Sonova launched its first OTC hearing aid with an "In-Clinic Care Package" Option.
On November 1, 2022, Cochlear Limited received the U.S. Food and Drug Administration (FDA) approval for the CochlearTM Nucleus 8 Sound Processor.

Why Purchase the Report?

To visualize the global audiology devices market segmentation based on technology, product type, indication, distribution channel and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of audiology devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global audiology devices market report would provide approximately 69 tables, 71 figures, and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Technology
3.2. Snippet by Product Type
3.3. Snippet by Indication
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in the number of device launches
  - 4.1.1.2.
- 4.1.2. Restraints
  - 4.1.2.1. High costs associated with the devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Digital *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Analog

8. By Product Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.1.2. Market Attractiveness Index, By Product Type
8.2. Hearing Aids *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cochlear Implants
8.4. Bone Conduction Devices
8.5. Diagnostic Devices

9. By Indication

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.1.2. Market Attractiveness Index, By Indication
9.2. Otosclerosis *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Meniere's Disease
9.4. Acoustic Tumors
9.5. Otitis Media
9.6. Others

10. By Distribution Channel

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Retail Sales *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Online Stores
10.4. Government Purchases
10.5. E-Commerce
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Oticon Medical *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Med-EL
13.3. Starkey Hearing Technologies
13.4. Phonak
13.5. Advanced Bionics
13.6. Audina Hearing Instruments, Inc.
13.7. Coselgi
13.8. Sonova AG
13.9. WS Audiology A/S
13.10. BHM-Tech Produktionsgesellschaft mbH